| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pharmesis International Ltd (SGX: P31)
Â
P31 Technical Analysis
3
| As on 25th Aug 2015 P31 Share Price closed @ 0.04 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.04 & Buy for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
Â
Â
P31 Share Price
| Open | 0.04 | Change | Price | % |
| High | 0.04 | 1 Day | 0.00 | 0.00 |
| Low | 0.04 | 1 Week | 0.00 | 0.00 |
| Close | 0.04 | 1 Month | 0.00 | 0.00 |
| Volume | 2000 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.79 | 52 Week Low 0.41 | ||||
Â
SGX Singapore Most Active Stocks
| N21 | 131.00 | 0.00% |
| A50 | 0.13 | 0.00% |
| 5DE | 0.02 | 0.00% |
| 576 | 0.15 | 0.00% |
| EG0 | 0.03 | 0.00% |
| C8R | 0.06 | 0.00% |
| B22 | 0.09 | 0.00% |
| 5ME | 0.20 | 0.00% |
| E5H | 0.40 | 0.00% |
| Z74 | 3.75 | 0.00% |
Â
SGX Singapore Top Gainers Stocks
Â
SGX Singapore Top Losers Stocks
Â
Â
| P31 Daily Charts |
P31 Intraday Charts |
Whats New @ Bazaartrend |
P31 Free Analysis |
|
|
Â
P31 Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
Â
P31 Target for Month April
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
Â
P31 Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
Â
P31 Target for Year 2021
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
Â
Pharmesis International Ltd ( SGX Singapore Symbol : P31 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
Â
P31 Business Profile
Pharmesis International Ltd., an investment holding company, develops, manufactures, and sells western medicines, health tonic products, and traditional Chinese medicine (TCM) formulated products in the PeopleÂ’s Republic of China. The company operates through Western Drugs, TCM Formulated Drugs, and Distribution segments. It is also involved in the wholesale of chemical drugs, biological raw products, TCMs, antibiotics, and antibiotics agents. The company offers its western medicines and TCM formulated products in the form of tablets, granules, pills, etc. Its products comprise Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Xiao Shi Jian Pi tablets for the treatment of flatus, inappetency, dyspepsy, and spleen weakness; and LianPu ShuangQing for the treatment of acute inflammation, such as dysentery and intestinal infection. Pharmesis International Ltd. also offers Shulinghou tablets, which clear heat and regenerate body fluid, as well as for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Er Ding granules for the treatment of jaundice, as well as clears heat toxics; and AFenKa for the treatment of migrane, pain, headache, cold, nasosinusitis, muscle pain, menstrual pain, toothache, and arthritis. In addition, the company provides Wuling Jiao Nang granules, which disperse water accumulation, regulate water circulation, and dispel dampness; Bear Bile and Bulbus Fritillariae oral liquid for the treatment of phlegmheat cough; and Gansu for the treatment of acute and chronic hepatitis. Pharmesis International Ltd. markets its western drugs under the Kinna brand name; and TCM formulated drugs under the Longlife brand name to approximately 2,000 hospitals through its sales and marketing personnel. The company was founded in 1996 and is headquartered in Chengdu, the PeopleÂ’s Republic of China.
Â
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
